Found "Digital Medicine": 200 results
Belt and Road: Cross-National Learning to Support Evidence-Informed Practice in Pediatric Healthcare
Beijing Children’s Hospital, Capital Medical University, National Centre for Children’s Health of China are committed to advancing skills in conducting comprehensive clinical evaluations of medicines. This commitment is evident through a variety of initiatives, including workshops, training, and aca
Implementing Health Tech for UHC: Real-World Lessons from PMAC 2025
The rapid advancement of technology is reshaping global health, offering new opportunities to strengthen health systems. The Prince Mahidol Award Conference (PMAC) 2025, under the theme of “Harnessing Technologies in an Age of AI to Build a Healthier World,” provided invaluable insights into the com
Is AI the Answer? Exploring the Challenges and Solutions of AI in Strengthening Health Systems: Insights from PMAC 2025
At the recent Prince Mahidol Award Conference (PMAC) 2025, the Health Intervention and Technology Assessment Program (HITAP) Foundation hosted a side meeting on the role of artificial intelligence (AI) in healthcare. This meeting “Is AI a Panacea for the Health Sector? Navigating the Barriers to Ado
OxyContin abuse down with time-release formula
(Reuters Health) – There’s more evidence that the new formulation of OxyContin, the time-release version of oxycodone, is discouraging abuse of the powerful drug.But the reformulation, introduced in August 2010 to make it harder to crush the medicine into powder, limiting the ability to snort, injec
California county wants drug makers to pay for pill disposal
(Reuters) – Pharmaceutical companies selling drugs in parts of the San Francisco Bay area would be required to submit plans for incinerating or safely disposing of unused medication under a plan advanced by county officials this week.The measure, billed by supporters as the first of its kind in the
Alzheimer’s ‘early signs timeline developed’
Scientists have assembled a “timeline” of the unseen progress of Alzheimer’s before symptoms appear.A team at Washington University School of Medicine looked at families with a genetic risk of the disease.Writing in the New England Journal of Medicine, they say signs appeared up to 25 years before t
Merck osteoporosis drug, company pipeline win more respect
Merck, the second-biggest U.S. drugmaker, on Wednesday said outside monitors recommended that its late-stage study of odanacatib, a new type of treatment, be stopped early because data has already shown it reduces fractures. Shares of Merck rose 4.2 percent on Thursday, on boosted hopes for the medi
Scientists see AIDS vaccine within reach after decades
(Reuters) – At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two years.But a string of failed attempts – punctuated by a 2007 trial in which a Merck vaccine appeared to make p
Analysis: U.S. governors make risky political bet on healthcare funds
(Reuters) – Republican governors bent on rejecting the healthcare law’s expanded insurance coverage for millions of low-income Americans may see their gambit backfire if their party fails to sweep the November elections.Five governors have vowed to opt out of the Medicaid expansion for low-income pe
AstraZeneca starts new study of heart drug versus rival
(Reuters) – AstraZeneca is to conduct a new global clinical trial of key new heart drug Brilinta involving 11,500 patients with peripheral artery disease, Britain’s second biggest drugmaker said on Tuesday.Peripheral artery disease affects around 27 million people in Europe and North America, with s
10 / Page